000			04106cam a2200445Ii 4500
999			_c96302 _d96302
001			96302
003			ES-MaUEC
005			20230102112748.0
006			m o d
007			cr cnu|||unuuu
008			170707s2017 sz a o 001 0 eng d
020			_a3319571915
020			_a3319571931 _q(electronic bk.)
020			_a9783319571911
020			_a9783319571935 _q(electronic bk.)
020			_z9783319571911 _q(print)
040			_aN$T _cN$T _dEBLCP _dGW5XE _dN$T _dYDX _dOCLCO _dOCLCF _dNJR _dUAB _dOCLCO _dESU _dAZU _dUPM _dIOG _dCOO _dOCLCQ _dMERER _dVT2 _dOCLCQ _dOCLCO _dJG0 _dOCLCO _dOCLCA _dES-MaUEC _bspa
050		4	_aRC365 _b2017 EB
245	0	0	_aNeurodegenerative diseases : _bpathology, mechanisms, and potential therapeutic targets _cPhilip Beart, Michael Robinson, Marcus Rattray, Nicholas J. Maragakis, editors.
264		1	_aCham, Switzerland _bSpringer _c2017.
300			_a1 recurso en línea (xiv, 542 páginas) _bilustraciones (algunas a color)
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF
490	0		_aAdvances in neurobiology _x2190-5215 _vvolume 15
500			_aIncluye índice
500			_aSpringerLink
505	0		_aPart 1: Major Neurodegenerative Conditions -- Alzheimer's Disease -- Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons -- Clinical Aspects of Alzheimer's Disease -- Parkinson's Disease: Basic Pathomechanisms and a Clinical Overview -- Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets -- The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers -- Motoneurone Disease -- Basic Science -- Motoneurone Disease -- Clinical -- Multiple Sclerosis -- Basic and Clinical -- Part 2: Other Neurological Conditions -- Schizophrenia--Basic and Clinical -- Stroke -- Basic and Clinical -- Epileptic Encephalopathies as Neurodegenerative Disorders -- Neurodegeneration and Pathology in Epilepsy-Clinical and Basic Perspectives -- Prion Disease -- Basic and Clinical -- Leukodystrophies -- Basic and Clinical -- Traumatic Brain Injury as a Trigger of Neurodegeneration -- Part 3: Key Background and Key Technologies -- Cell Death Mechanisms of Neurodegeneration -- Neuroglia: Functional Paralysis and Reactivity in Alzheimer's Disease and Other Neurodegenerative Pathologies -- Advances in Neuroimaging for Neurodegenerative Disease -- Gene Linkage and Systems Biology -- Biomarkers in Neurodegenerative Diseases.
520	3		_aProvides a timely overview of critical advances in molecular and cellular neurobiology, covers key methodologies driving progress, and highlights key future directions for research on neuronal injury and neurodegeneration relevant to neuronal brain pathologies. The editors bring together contributions from internationally recognized workers in the field to provide an up to date account of how and why molecular and cellular neurobiology is such an important area for clinical neuroscience. Understanding the molecular aspects of a number of neurodegenerative conditions such as Parkinson's or Alzheimer's disease for the purpose of improving patient management remains a major challenge of neurobiology be it from the basic or clinical perspective. A strategic evaluation of research contributions and the power of modern methods will help advance knowledge over the next years.
988			_aEBOOK, asignarmaterias, EBSPRINGER_2017D
650		7	_aSistema nervioso _xDegeneración _2embne _9313064
700	1		_aBeart, P. M. _q(Philip M.), _eeditor literario
700	1		_aMaragakis, Nicholas J., _eeditor literario
700	1		_aRattray, Marcus, _eeditor literario
700	1		_aRobinson, Michael _c(Translator) _eeditor literario _949227
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-57193-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2018 _dz _e- _zSI